Indian Prime Minister Narendra Modi has appealed to citizens to conserve fuel and avoid unnecessary travel due to rising oil prices from the Iran war. Bloomberg's Ruchi Bhatia reports. (Source: Bloomberg)
Indian Prime Minister Narendra Modi has appealed to citizens to conserve fuel and avoid unnecessary travel due to rising oil prices from the Iran war. Bloomberg's Ruchi Bhatia reports. (Source: Bloomberg)
(RTTNews) - Indian shares were sharply lower in early trade on Monday after U.S. President Donald Trump and Iran rejected each other's latest peace proposals to end the war in the Middle East, keeping the Strait of Hormuz largely closed and raising doubts about the durability of
(RTTNews) - Indian shares were sharply lower in early trade on Monday after U.S. President Donald Trump and Iran rejected each other's latest peace proposals to end the war in the Middle East, keeping the Strait of Hormuz largely closed and raising doubts about the durability of
RadNet press release ( RDNT ): Q1 Non-GAAP EPS of -$0.28 misses by $0.49 . Revenue of $575.63M (+22.1% Y/Y) misses by $28.09M . Total Company Adjusted EBITDA was $63.3 million in the first quarter of 2026 as compared with $46.4 million in the first quarter of 2025, an increase of 36.3%. RadNet revises full-year 2026 Imaging Center guidance levels with increases to Revenue, Adjusted EBITDA and Free...
RadNet press release ( RDNT ): Q1 Non-GAAP EPS of -$0.28 misses by $0.49 . Revenue of $575.63M (+22.1% Y/Y) misses by $28.09M . Total Company Adjusted EBITDA was $63.3 million in the first quarter of 2026 as compared with $46.4 million in the first quarter of 2025, an increase of 36.3%. RadNet revises full-year 2026 Imaging Center guidance levels with increases to Revenue, Adjusted EBITDA and Free Cash Flow and reaffirms all Digital Health guidance ranges. 2026 Revised Guidance RadNet amends its previously announced guidance levels as follows: Imaging Center Segment OriginalGuidance Range RevisedGuidance Range Total Net Revenue $2,325 - $2,375 million $2,355 - $2,405 million vs. consensus of $2.45B Adjusted EBITDA (1) $335 - $348 million $340 - $353 million Capital Expenditures ( a ) $165 - $175 million $165 - $175 million Cash Interest Expense ( b ) $45 - $50 million $45 - $50 million Free Cash Flow ( 2 ) $105 - $115 million $112 - $122 million Click to enlarge (a) Net of proceeds from the sale of equipment and New Jersey Imaging Network capital expenditures.(b) Net of payments from counterparties on interest rate swaps and interest income from our cash balance recorded in Other Income. Digital Health Segment OriginalGuidance Range RevisedGuidance Range Total Net Revenue $135 - $145 million $135 - $145 million Adjusted EBITDA (1) Before Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI $10 - $12 million $10 - $12 million Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI $17 - $19 million $17 - $19 million Capital Expenditures $9 - $12 million $9 - $12 million Free Cash Flow ( 2 ) Before Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI $(1) - $3 million $(1) - $3 million Free Cash Flow ( 2 ) After Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI $(17) - $(19) million $(17) - $(19) million Click to enlarge More on RadNet RadNet, Inc. (RDNT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript RadNet's Pullback Off...
ozgurcankaya/iStock via Getty Images Overview Business development companies continue to suffer as a result of high interest rates. Sixth Street Specialty Lending ( TSLX ) has been able to navigate its headwinds, but there are very few signs of growth. When I previously covered TSLX, I issued a hold rating because of the limited growth catalysts and declining earnings. Thankfully, TSLX's share pri...
ozgurcankaya/iStock via Getty Images Overview Business development companies continue to suffer as a result of high interest rates. Sixth Street Specialty Lending ( TSLX ) has been able to navigate its headwinds, but there are very few signs of growth. When I previously covered TSLX, I issued a hold rating because of the limited growth catalysts and declining earnings. Thankfully, TSLX's share price has remained resilient, and the total return is in positive territory. However, TSLX recently reported its Q1 earnings, so I wanted to revisit the current value proposition, outlook, and dividend sustainability for the remainder of 2026. When I previously covered TSLX, it traded at a small premium to NAV of 4.53%. Following the recent positive momentum, TSLX now trades at a larger premium to NAV of 10.47%. Valuations across the BDC market can be a bit tricky right now. However, TSLX remains at the more attractive end of its historical price to NAV range. For reference, TSLX has traded at a much higher average premium to NAV of 24.32% over the last five years. So if the BDC market improves and TSLX is capable of growing its NAV, this can be a great time to accumulate shares. CEFData.com Despite the attractive valuation, there are still some risks for investors to consider. For instance, the NAV has maintained a downward trend for more than a year straight. Management has struggled to locate new opportunities to invest in, and non-accruals as a percentage of fair portfolio value have more than doubled since my last coverage. In a scenario where interest rates remain high, this can threaten the future growth of TSLX. Even when the new investments do eventually materialize into higher net investment income, it can take several quarters to play out. Therefore, I anticipate that there could be more pain ahead before things start to improve. Q1 Earnings Show Further Declines According to the latest portfolio overview , TSLX has total investments at fair value of $3.4B that are ...
MoonLake Immunotherapeutics press release ( MLTX ): Q1 GAAP EPS of -$0.98 misses by $0.07 . More on MoonLake Immunotherapeutics MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day - Slideshow MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript MoonLake upgraded at Rothschild & Co Redburn citing potential FDA ...
MoonLake Immunotherapeutics press release ( MLTX ): Q1 GAAP EPS of -$0.98 misses by $0.07 . More on MoonLake Immunotherapeutics MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day - Slideshow MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript MoonLake upgraded at Rothschild & Co Redburn citing potential FDA nod for lead drug Seeking Alpha’s Quant Rating on MoonLake Immunotherapeutics
Allendale, Northumberland: Once again, wildlife has made a home in our garden, in part because they feel safe here A big moon is cresting the Scots pine as I sit at an upstairs window looking down on to the garden. Awaiting the dusk emergence of a female tawny owl has become an evening ritual. After a day spent in the confines of a nest box in our sycamore tree, her departure shifts back by a few ...
Allendale, Northumberland: Once again, wildlife has made a home in our garden, in part because they feel safe here A big moon is cresting the Scots pine as I sit at an upstairs window looking down on to the garden. Awaiting the dusk emergence of a female tawny owl has become an evening ritual. After a day spent in the confines of a nest box in our sycamore tree, her departure shifts back by a few minutes every night. Completely silent, she drops towards the woodland border and skims the plants, each time on the same trajectory, a grey shadow in the gloaming. Another movement on the path below catches my eye: a woodcock slinking along, using the box hedge to disguise her passage. If I hadn’t been watching for the owl I would never have known that she too is nesting somewhere in the garden’s thick leafiness. In July 2023, I wrote about a woodcock nesting in a flower border a few metres from the house, four chicks successfully hatching from four eggs. Last year, another attempt was disturbed by a cat captured on trailcam. This may be the same bird returned for a third time. Woodcocks are extremely secretive birds, their close proximity to a house very unusual. Continue reading...
International Tower Hill press release ( THM ): Q1 GAAP EPS of $0.01. As at March 31, 2026, the company had cash and cash equivalents of $64.69M compared to $1.35M at December 31, 2025. As at May 7, 2026, management believes that the company has sufficient financial resources to maintain its operations for the next twelve months. More on International Tower Hill Mines Ltd. International Tower Hill...
International Tower Hill press release ( THM ): Q1 GAAP EPS of $0.01. As at March 31, 2026, the company had cash and cash equivalents of $64.69M compared to $1.35M at December 31, 2025. As at May 7, 2026, management believes that the company has sufficient financial resources to maintain its operations for the next twelve months. More on International Tower Hill Mines Ltd. International Tower Hill Mines As A Cheap Lever On The Price Of Gold, A Change Worth $115 Million Financial information for International Tower Hill Mines Ltd.
Marriott ( MAR ) declares $0.73/share quarterly dividend , 9% increase from prior dividend of $0.67. Forward yield 0.83% Payable June 30; for shareholders of record May 22; ex-div May 22. See MAR Dividend Scorecard, Yield Chart, & Dividend Growth. More on Marriott Marriott International Proves Resilient To The Iran Shock Marriott International: Its Upside Has Already Traveled Too Long, Too Far Mar...
Marriott ( MAR ) declares $0.73/share quarterly dividend , 9% increase from prior dividend of $0.67. Forward yield 0.83% Payable June 30; for shareholders of record May 22; ex-div May 22. See MAR Dividend Scorecard, Yield Chart, & Dividend Growth. More on Marriott Marriott International Proves Resilient To The Iran Shock Marriott International: Its Upside Has Already Traveled Too Long, Too Far Marriott International, Inc. (MAR) Q1 2026 Earnings Call Transcript Marriott expects 2026 adjusted EPS of $11.38 to $11.63 as it raises full-year global RevPAR outlook to 2% to 3% Travel stocks move higher as oil tumbles on US.-Iran deal talks
Illinois Tool Works Inc. ( ITW ) declares $1.61/share quarterly dividend , in line with previous. Forward yield 2.52% Payable July 10; for shareholders of record June 30; ex-div June 30. See ITW Dividend Scorecard, Yield Chart, & Dividend Growth. More on Illinois Tool Works Inc. Illinois Tool Works: Tricky In 2026, I Say 'Hold' Illinois Tool Works Inc. 2026 Q1 - Results - Earnings Call Presentatio...
Illinois Tool Works Inc. ( ITW ) declares $1.61/share quarterly dividend , in line with previous. Forward yield 2.52% Payable July 10; for shareholders of record June 30; ex-div June 30. See ITW Dividend Scorecard, Yield Chart, & Dividend Growth. More on Illinois Tool Works Inc. Illinois Tool Works: Tricky In 2026, I Say 'Hold' Illinois Tool Works Inc. 2026 Q1 - Results - Earnings Call Presentation Illinois Tool Works Inc. (ITW) Q1 2026 Earnings Call Transcript ITW projects $11.10-$11.50 2026 GAAP EPS while maintaining 1%-3% organic growth outlook Illinois Tool Works Inc. GAAP EPS of $2.66 beats by $0.10, revenue of $4.02B beats by $10M
Popular ( BPOP ) declares $0.75/share quarterly dividend , in line with previous. Forward yield 2.01% Payable July 1; for shareholders of record May 29; ex-div May 29. See BPOP Dividend Scorecard, Yield Chart, & Dividend Growth. More on Popular Popular's Popularity With Mr. Market Isn't Surprising Popular: Attractive But Not Stable Popular, Inc.: A Strong Bank, But Not A Cheap Stock Anymore Popula...
Popular ( BPOP ) declares $0.75/share quarterly dividend , in line with previous. Forward yield 2.01% Payable July 1; for shareholders of record May 29; ex-div May 29. See BPOP Dividend Scorecard, Yield Chart, & Dividend Growth. More on Popular Popular's Popularity With Mr. Market Isn't Surprising Popular: Attractive But Not Stable Popular, Inc.: A Strong Bank, But Not A Cheap Stock Anymore Popular targets 2026 net interest income growth at upper end of 5%-7% range while trimming expense outlook to 2%-3% Popular Q1 2026 Earnings Preview
We have put together stories from our coverage last weekend to help you stay informed about news across Asia and beyond. If you would like to see more of our reporting, please consider subscribing. 1. Could omega-3 supplements hurt the brain? Chinese military study flags risks 2. Hong Kong schools record net student rise for 2 years straight 3. Trump heads to China weakened as Xi gains leverage ah...
We have put together stories from our coverage last weekend to help you stay informed about news across Asia and beyond. If you would like to see more of our reporting, please consider subscribing. 1. Could omega-3 supplements hurt the brain? Chinese military study flags risks 2. Hong Kong schools record net student rise for 2 years straight 3. Trump heads to China weakened as Xi gains leverage ahead of summit 4. ‘Foreigner won’: Filipinos divided over pageant winner’s US roots 5. Singapore...
Fund performance Columbia Select Short Corporate Income Fund Institutional Class shares returned 0.11% for the three months ending March 31, 2026. The fund's primary benchmark, the Bloomberg U.S. 1–5 Year Corporate Index, returned 0.09% for the same period. Market overview The first quarter of 2026 was dominated by the outbreak of armed conflict between the United States/Israel and Iran, which beg...
Fund performance Columbia Select Short Corporate Income Fund Institutional Class shares returned 0.11% for the three months ending March 31, 2026. The fund's primary benchmark, the Bloomberg U.S. 1–5 Year Corporate Index, returned 0.09% for the same period. Market overview The first quarter of 2026 was dominated by the outbreak of armed conflict between the United States/Israel and Iran, which began on February 28. The conflict effectively disrupted transit through the Strait of Hormuz, a chokepoint for roughly 20% of global oil supply. Diplomatic signals have been mixed throughout the quarter — the U.S. has reported productive indirect talks while Iran has rejected direct negotiations and asserted sovereignty over the Strait. President Trump noted that discussions with Iran are ongoing and that the U.S. holds "all the cards." The emphasis on further escalation before any resolution suggests markets may face continued geopolitical uncertainty well into the second quarter. U.S. equity markets struggled under the weight of geopolitical risk and rising rates for much of the quarter before rallying on March 31, when indices saw their best single-day gains since May 2025 on hopes for a resolution to the conflict. Even with the late rally, the S&P 500 Index finished the first quarter down 4.33%, its worst first-quarter performance since 2022. The Nasdaq Composite fell -7.11%, the Dow Jones Industrial Average -3.58%, and the Russell 2000 Index eked out a 0.89% gain. On the economic data front, fourth-quarter 2025 gross domestic product (GDP) growth was revised down to just 0.7% annualized, a sharp step-down from the 4.4% pace in the third quarter, though full-year 2025 growth still came in at a respectable 2.1%. The Atlanta Fed's GDP Now tracker for first quarter 2026 was 1.9% as of April 1. March employment data was better than consensus expectations, with nonfarm payrolls rising 178,000 (versus 78,000 consensus, although February was revised down to -133,000 from -92,000...